The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tislelizumab plus chemotherapy in patients with advanced brain metastases of non-squamous non-small cell lung cancer: A multicenter, prospective, open-label phase 2 study.
 
Yan Huang
No Relationships to Disclose
 
Qitao Yu
No Relationships to Disclose
 
Nong Yang
No Relationships to Disclose
 
Li Liu
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Qiming Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Yuanyuan Zhao
No Relationships to Disclose
 
Yunpeng Yang
No Relationships to Disclose
 
Wei Jiang
No Relationships to Disclose
 
Liping Tan
No Relationships to Disclose
 
Chunhua Zhou
No Relationships to Disclose
 
Fanxu Zeng
No Relationships to Disclose
 
Kai Zhang
No Relationships to Disclose
 
You Qin
No Relationships to Disclose
 
Shuai Zhang
No Relationships to Disclose
 
Shuxiang Ma
No Relationships to Disclose
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Innovent Biologics
Speakers' Bureau - AstraZeneca; BeiGene; HenRui; Innovent Biologics; Roche China
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); Junshi Pharmaceuticals (Inst); QiLu Pharmaceutical (Inst)